View Clinical Trial (Medical Research Study)
Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection - NCT00395018-70112(Clinical Trial 154592)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
New Orleans |
|
State:
|
|
LA |
| Zip Code: |
|
70112 |
| Conditions: |
|
Hepatitis B, Chronic |
| Purpose: |
|
The purpose of this clinical research study is to learn if the study drug entecavir will
prevent the recurrence of hepatitis B virus in subjects who receive an orthotopic liver
transplant (OLT).
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Patients receiving orthotopic liver transplant (OLT) due to end-stage liver disease
because of chronic HBV infection, with HBV-DNA < 172 IU/mL (approximately < 1000
copies/mL) prior to liver transplant
- Must have detectable hepatitis B surface antigen (HBsAg) at screening and for at
least 24 weeks prior to screening
Exclusion Criteria:
- Patients with hepatocellular carcinoma with evidence of extrahepatic spread, multiple
tumors ≥ 6.5 cm in diameter or there is up to three nodules ≥ 4.5 cm in diameter and
total tumor diameter is ≥ 8 cm
- Co-infection with human immunodeficiency virus (HIV), cytomegalovirus (CMV),
Epstein-Barr virus (EBV) or hepatitis C virus (HCV) |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
February 1, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|